pentobarbital will lower the extent or impact of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; powerful cytochrome P450 enzyme inducers minimize systemic exposure to roflumilast and may reduce the therapeutic efficiencyAmber's sister made a 'malicious' report back to kid bas